CNMD
Conmed Corp Health Care Electromedical & Electrotherapeutic Apparatus Russell 3000
$44.29Close
$1.4BMarket cap
$32.11 – $51.8652-week range
Jan 27, 2027Next report · estimated
Highlights
Strengths
- Earnings growing EPS +614% year on year, faster than the quarter before (+603 pts)
Cautions
- Trend not confirmed 6 of 8 conditions · under the 50-day, RS under 70
- Lagging the market RS 43 · weaker than 57% of stocks over 12 months
- Distribution down-day volume 1.6× up-day volume over 50 sessions
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
15%
1wk
down 10.1%
price change
1mo
down 4.2%
price change
12-month return
0%
market up 11% ·
its own down 16%
F-score
6 / 9
Mixed
Altman Z
1.92
Moderate risk
P/E
29.4×
price / earnings
PEG
—
P/E / EPS growth
P/B
1.3×
price / book
Earnings yield
up 4.7%
EBIT / enterprise value
Cheaper than
80%
of the market · cheap
Revenue growth
up 5%
year on year
EPS growth
up 614%
latest quarter · +603 pts
Sales growth
down 1%
latest quarter · -1 pts
ROE
up 5%
return on equity
Free cash margin
up 11%
$150.9M FCF
D/E
0.81
long-term debt / equity
Net debt / EBITDA
7.7×
Interest cover
3.3×EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- gross margin narrowed
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- no new shares issued
- assets working harder
Repair signals
- Long-term debt down 8% ($0.9B → $0.8B)
Trade setup
ATR%
4.4%
$1.94 a day · 2×ATR $40.41
RS
43 / 99
vs the universe
Trend
6 / 8
under the 50-day, RS under 70
Relative volume
1.1×
vs 50-day average
Up/down volume
0.61
50 sessions
Implied move
—
no scheduled report
Trend template · 6 of 8
- Price above the 50-day average: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Heavily indebted Net debt is 7.7 times EBITDA — roughly 8 years of earnings before interest, tax and depreciation to repay borrowings in full.
- Gross margin narrowing Gross margin fell from 56.1% to 54.6%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported
Oct 28, 2026
Results reaction
Oct 28, 2026-3% vs market2 sessions after results
Financials
- Gross 55%
- Net 3%
- Free cash 11%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $862.5M | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| Gross margin | 53% | 56% | 55% | 54% | 56% | 55% |
| Operating income | $46.0M | $109.7M | $70.1M | $120.6M | $200.3M | $102.6M |
| Net income | $9.5M | $62.5M | -$80.6M | $64.5M | $132.4M | $47.1M |
| Net margin | 1% | 6% | -8% | 5% | 10% | 3% |
| Earnings per share | $0.32 | $1.94 | -$2.68 | $2.04 | $4.25 | $1.51 |
| Free cash flow | $51.5M | $96.9M | $11.6M | $106.3M | $153.9M | $150.9M |
| Free cash margin | 6% | 10% | 1% | 9% | 12% | 11% |
| Cash | $27.4M | $20.8M | $28.9M | $24.3M | $24.5M | $40.8M |
| Long-term debt | $753.6M | $684.7M | $1.1B | $973.8M | $905.8M | $834.9M |
| Shareholders' equity | $709.0M | $785.4M | $745.5M | $834.2M | $962.7M | $1.0B |
| Shares outstanding | 31.30m | 31.30m | 31.30m | 31.30m | 31.30m | 31.30m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 28, 2026 | Quarterly ↗ | Sep 30, 2026 | 28d |
| Jul 29, 2026 | Quarterly ↗ | Jun 30, 2026 | 29d |
| Feb 17, 2026 | Annual ↗ | Dec 31, 2025 | 48d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Jul 31, 2025 | Quarterly ↗ | Jun 30, 2025 | 31d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 18, 2025 | Annual ↗ | Dec 31, 2024 | 49d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| Apr 25, 2024 | Quarterly ↗ | Mar 31, 2024 | 25d |
| Feb 28, 2024 | Annual ↗ | Dec 31, 2023 | 59d |
| Oct 26, 2023 | Quarterly ↗ | Sep 30, 2023 | 26d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 28, 2026 | Results ↗ |
| Jul 29, 2026 | Results ↗ |
| Jun 17, 2026 | Director or officer change · Regulation FD ↗ |
| Jun 4, 2026 | Material agreement ↗ |
| Jun 1, 2026 | Material agreement · New obligation ↗ |
| May 20, 2026 | Director or officer change · Charter or bylaws · Shareholder vote ↗ |
| Apr 29, 2026 | Results ↗ |
| Mar 13, 2026 | Director or officer change ↗ |
| Jan 28, 2026 | Results ↗ |
| Jan 12, 2026 | Regulation FD ↗ |
| Jan 8, 2026 | Director or officer change ↗ |
| Dec 5, 2025 | Regulation FD ↗ |